To include your compound in the COVID-19 Resource Center, submit it here.

Takeda to acquire Nycomed

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) will acquire Nycomed (Zurich, Switzerland) for EUR 9.6 billion ($13.6

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE